
Ed Gillis travels to advance Vasalgel
Ed Gillis, CEO of Revolution Contraceptives, the social venture company tasked with developing Vasalgel for Parsemus Foundation, traveled to Paris this spring to exchange ideas
Ed Gillis, CEO of Revolution Contraceptives, the social venture company tasked with developing Vasalgel for Parsemus Foundation, traveled to Paris this spring to exchange ideas
As part of Parsemus Foundation’s commitment to animal welfare, we’re proud to be a new sponsor of the Janet Wood Innovation Award, which supports the
Usually, the development of a medical device happens out of the public eye, but in our case, we have shared information with the public and
Good news for Vasalgel! Ed Gillis has joined the team as CEO of Revolution Contraceptives, LLC, the social venture company that is developing Vasalgel under
You can see an “inside view” of Vasalgel in action thanks to this video representation with animation by Filip Spasev and Will Justice. The project
Recent test batch challenges scientists We’ve been happy to share our progress with you — and so much has been accomplished this year! But we
Monkeys are smart and social, and for humane reasons must be housed together. But how do you house male and female animals in social groups
Once Vasalgel male contraceptive is available, how will the men who have it know that it’s still in place? Of course the most important thing
A key goal for Vasalgel is that it would not only be an effective long-acting male contraceptive, but also be reversible: a Vasalgel user who
THANK YOU to all the Vasalgel supporters who stepped up to meet the $5,000 one-day challenge last week. One of Vasalgel’s biggest supporters — a
And if you don’t find a match there, this slightly more complex clinical trials finder includes studies sponsored by companies as well: